IMCD stock at EUR 100.08, volume 89.3% below average

Published on 10/12/2026 at 14:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

IMCD stock costs EUR 100.08 on October 12, 2026, below the EUR 100.55 Xetra close. Its 52-week high is EUR 105.05.

Key points in brief

IMCD stock was at EUR 100.08 at Lang & Schwarz on October 12, 2026 at 2:29 p.m. CEST, 0.47 percent below the Xetra close of October 9, 2026.
Trading volume was 16,101 shares versus an average of 150,211 shares on October 12, 2026.
The 52-week range was EUR 68.14 to EUR 105.05, while market capitalization stood at EUR 5.9 billion.
Goldman Sachs set a EUR 133.00 12-month target in its October conviction list, according to CNBC.

Pop-Art-Comic-Illustration eines Labortechnikers beim Mischen bunter Chemikalien im Retro-Stil — Pop-Art-Comic mit Chemielabor-Szene interpretiert kreativ die Branche von IMCD N.V., ISIN NL0010801007, in bunter Comic-Optik, Illustration mit AI erstellt.

IMCD (NL0010801007) was at EUR 100.08 at Lang & Schwarz on October 12, 2026 at 2:29 p.m. CEST, 0.47 percent below the Xetra close of October 9, 2026 at EUR 100.55. The intraday quote puts the specialty chemicals distributor 4.73 percent below its 52-week high of EUR 105.05.

Volume remains below average

Trading volume stood at 16,101 shares on October 12, 2026, compared with an average of 150,211 shares. That is 89.29 percent below the average, making turnover the clearest short-term contrast with the share price level.

The Lang & Schwarz bid was EUR 100.00 and the ask was EUR 100.15 at 2:29 p.m. CEST. The spread between the two quotes was EUR 0.15, while the current price remained EUR 0.47 below the latest Xetra close.

Range leaves limited room above

IMCD traded inside a 52-week range of EUR 68.14 to EUR 105.05 as of October 12, 2026. The current EUR 100.08 price was 46.90 percent above the low and 4.73 percent below the high, placing the stock closer to the upper end of its annual range.

Market capitalization was EUR 5.9 billion on October 12, 2026, and the price-to-earnings ratio was 25.65. The dividend yield was 0.02 percent, so the valuation picture is driven primarily by earnings expectations rather than current income.

Comparison with peers

IMCD: minus 0.47 percent, P/E 25.65, market capitalization EUR 5.9 billion

Brenntag (Xetra, EUR): minus 0.29 percent, P/E 24.60, market capitalization EUR 8.9 billion

Sartorius (Xetra, EUR): plus 0.73 percent, P/E 90.85, market capitalization EUR 17.5 billion

Target and next reporting date

CNBC reported on October 2, 2026 that Goldman Sachs added IMCD to its October European conviction list and set a 12-month price target of EUR 133.00. The target lies 32.90 percent above the Lang & Schwarz price of EUR 100.08, although that comparison uses different reference dates for the target and the intraday quote.

IMCD's investor-relations calendar lists publication of the first nine months 2026 results for November 5, 2026, according to IMCD. The date is the next scheduled reporting milestone for the company.

IMCD stock stays below its high

At EUR 100.08, IMCD stock was EUR 0.47 below the Xetra close of October 9, 2026 and EUR 4.97 below the 52-week high of EUR 105.05. The combination of a 25.65 price-to-earnings ratio and the EUR 133.00 Goldman target leaves the next results date as the main scheduled valuation checkpoint. The further course of trading is shown by the continuously updated real-time quote of IMCD stock.